Structural Heart Imaging Market to Reach USD 49,150.2 Million by 2033 at 12.4% CAGR; North America Leads with 40.7% Share - Key Players: GE HealthCare, Siemens Healthineers, Philips Healthcare

The global structural heart imaging market was valued at USD 19,995.6 million in 2025 and is projected to reach USD 49,150.2 million by 2033, growing at a CAGR of 12.4% during the forecast period from 2026 to 2033. The market is witnessing robust growth driven by increasing prevalence of structural heart diseases, rising adoption of minimally invasive cardiac procedures, and growing demand for advanced real time cardiac imaging technologies. Expanding utilization of echocardiography, cardiac computed tomography, magnetic resonance imaging, and fluoroscopy guided imaging systems in transcatheter valve replacement and repair procedures is significantly accelerating market expansion globally. In addition, continuous advancements in 3D and 4D imaging technologies, artificial intelligence integrated imaging platforms, and image guided procedural planning are improving diagnostic precision and procedural outcomes in structural heart interventions.

The market is also benefiting from increasing regulatory approvals, rising investments in cardiovascular imaging infrastructure, and expanding commercialization of next generation imaging solutions by major medical technology companies. Regulatory agencies such as the U.S. Food and Drug Administration (FDA) and European Medicines Agency (EMA) continue to support innovation in advanced cardiovascular imaging systems through streamlined approval pathways and safety initiatives. Companies including GE HealthCare, Siemens Healthineers, Philips Healthcare, and Canon Medical Systems Corporation are actively focusing on AI enabled cardiac imaging platforms, advanced visualization software, and integrated imaging solutions to strengthen their global market presence. Furthermore, increasing adoption of transcatheter structural heart procedures and growing demand for precision guided cardiovascular interventions are creating substantial growth opportunities for the market worldwide.

Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID): https://www.datamintelligence.com/download-sample/structural-heart-imaging-market?sai-v

Key Developments

February 2026: Rising adoption of AI-enabled multimodality cardiac imaging platforms across North America and Europe improved diagnostic precision for structural heart interventions including TAVR and TMVR procedures. Major companies including GE HealthCare, Siemens Healthineers, and Philips Healthcare accelerated deployment of advanced echocardiography and cardiac CT solutions.

January 2026: Increasing investments in hybrid catheterization laboratories across the United States, Germany, and Japan strengthened demand for real-time cardiac imaging technologies. Canon Medical Systems and Fujifilm Holdings Corporation expanded cardiovascular imaging portfolios supporting minimally invasive cardiac procedures.

December 2025: Growing prevalence of structural heart diseases and aging populations across Europe and North America accelerated adoption of advanced echocardiography, MRI, and cardiac CT technologies. Abbott Laboratories and Boston Scientific Corporation strengthened collaborations focused on imaging-guided cardiovascular interventions.

November 2025: Expansion of AI-powered cardiac imaging software and automated valve assessment technologies improved workflow efficiency and diagnostic reproducibility globally. GE HealthCare introduced advanced AI-enabled cardiovascular imaging systems supporting precision cardiology applications.

October 2025: Rising healthcare infrastructure modernization initiatives and increasing cardiovascular disease burden across Asia-Pacific strengthened deployment of advanced structural heart imaging systems. Samsung Medison and Mindray Medical International expanded regional cardiac imaging technologies supporting precision diagnostics.

September 2025: Increasing collaborations between imaging technology providers and healthcare institutions accelerated development of AI-assisted cardiac CT analysis and 3D echocardiography platforms. Siemens Healthineers expanded its AI-powered cardiovascular ultrasound portfolio across Europe and North America.

August 2025: Growing integration of multimodality imaging techniques, including CT, MRI, and echocardiography improved treatment planning and procedural safety for structural heart interventions globally. Cardiology centers across India and Europe have increased adoption of AI-assisted imaging analysis and strain imaging technologies.

July 2025: Rising adoption of transcatheter valve replacement and repair procedures across North America and Europe increased demand for high-resolution structural heart imaging systems. Medtronic plc, Edwards Lifesciences, and Terumo Corporation strengthened innovation in imaging-integrated cardiovascular intervention technologies.

June 2025: Increasing focus on minimally invasive procedures and outpatient cardiovascular treatment models accelerated demand for compact and AI-enhanced structural heart imaging systems globally. North America maintained market leadership, while Asia-Pacific emerged as the fastest growing regional market driven by expanding healthcare investments.

Key Players
Boston Scientific Corporation | Circle Cardiovascular Imaging Inc. | Absolute Medical Services, Inc. | Pie Medical Imaging B.V | Siemens Healthineers GmbH | Cardinal Health Inc. | Koninklijke Philips NV | GE HealthCare | Neusoft Medical Systems | Shimadzu Corporation | Others

Key Highlights
Boston Scientific Corporation - Holds a 14.8% share, driven by advanced cardiovascular intervention technologies, expanding structural heart treatment portfolio, and strong imaging-guided procedural capabilities.

Circle Cardiovascular Imaging Inc. - Holds a 12.2% share, supported by cardiac imaging software innovation, AI-powered cardiovascular analysis platforms, and growing adoption in structural heart diagnostics.

Absolute Medical Services, Inc. - Holds a 10.1% share, fueled by specialized cardiovascular imaging support services, integrated diagnostic workflow capabilities, and expanding healthcare provider partnerships.

Pie Medical Imaging B.V - Holds an 8.7% share, driven by quantitative cardiovascular imaging technologies, advanced echocardiography analysis software, and strong clinical research integration capabilities.

Siemens Healthineers GmbH - Holds a 7.9% share, supported by high-resolution cardiac imaging systems, AI-enabled diagnostic platforms, and broad hospital imaging infrastructure leadership.

Cardinal Health Inc. - Holds a 6.5% share, powered by integrated healthcare distribution networks, cardiovascular diagnostic support solutions, and expanding imaging equipment supply capabilities.

Koninklijke Philips NV - Holds a 5.8% share, driven by advanced echocardiography systems, real-time structural heart imaging technologies, and innovative interventional cardiology visualization platforms.

GE HealthCare - Holds a 4.9% share, supported by AI-driven cardiovascular imaging systems, advanced CT and ultrasound technologies, and strong global diagnostic imaging infrastructure.

Neusoft Medical Systems - Holds a 3.8% share, fueled by cost-effective medical imaging systems, expanding cardiovascular diagnostic capabilities, and growing healthcare technology adoption in Asia-Pacific.

Shimadzu Corporation - Holds a 2.9% share, driven by precision diagnostic imaging technologies, advanced angiography systems, and strong expertise in minimally invasive cardiovascular imaging solutions.

Others - Hold a combined 22.4% share, comprising regional medical imaging manufacturers, cardiovascular software developers, and emerging AI-driven diagnostic technology firms advancing structural heart imaging and interventional cardiology solutions globally.

Purchase Corporate License | Market Intelligence: https://www.datamintelligence.com/buy-now-page?report=structural-heart-imaging-market?sai-v

Market Drivers

Increasing prevalence of cardiovascular diseases, valvular heart disorders, and congenital heart abnormalities is significantly driving demand for advanced structural heart imaging solutions globally.

Growing adoption of minimally invasive cardiac procedures such as transcatheter valve replacement and repair therapies is accelerating the need for high-precision structural heart imaging technologies.

Rising demand for real-time cardiac visualization, accurate procedural guidance, and advanced diagnostic capabilities is strengthening utilization of multimodality heart imaging systems.

Increasing integration of echocardiography, cardiac CT, MRI, fluoroscopy, and 3D imaging platforms is improving diagnosis, treatment planning, and procedural outcomes in structural heart interventions.

Expansion of geriatric population and rising incidence of age-related cardiac disorders are contributing to higher adoption of structural heart imaging technologies worldwide.

Continuous advancements in AI-powered imaging software, image fusion technologies, and automated cardiac analysis systems are enhancing clinical efficiency and diagnostic accuracy.

Growing healthcare expenditure, expanding cardiac care infrastructure, and increasing awareness regarding early cardiovascular disease diagnosis are further propelling market growth globally.

Industry Developments

Rapid advancement in AI-enabled cardiac imaging platforms improving automated image interpretation, procedural planning, and real-time clinical decision support.

Increasing adoption of 3D and 4D echocardiography technologies enhancing visualization accuracy during structural heart interventions and transcatheter procedures.

Growing investments in hybrid operating rooms and image-guided cardiac intervention systems supporting expansion of minimally invasive cardiovascular procedures.

Expansion of cloud-based imaging platforms and integrated cardiovascular data management systems improving workflow efficiency and collaborative patient care.

Rising collaborations among medical imaging companies, cardiovascular device manufacturers, and healthcare institutions accelerating innovation in structural heart imaging technologies.

Strategic product launches and regulatory approvals for advanced cardiac CT, MRI, and intracardiac imaging systems supporting global market commercialization.

Continuous innovation in fusion imaging, catheter-based visualization technologies, and AI-assisted cardiac analytics improving procedural outcomes and patient management.

Regional Insights

North America 40.7% share: "Leads the market due to advanced cardiovascular healthcare infrastructure, high adoption of minimally invasive cardiac procedures, strong presence of major medical imaging companies, and increasing investments in structural heart interventions."

Europe 29.1% share: "Growth supported by rising prevalence of valvular heart diseases, expanding geriatric population, strong reimbursement frameworks, and increasing adoption of advanced cardiac imaging technologies."

Asia Pacific 23.5% share: "Fastest-growing region driven by improving healthcare infrastructure, rising cardiovascular disease burden, increasing healthcare expenditure, and expanding cardiac care investments in countries such as China, India, Japan, and South Korea."

Latin America 3.8% share: "Emerging growth supported by improving access to advanced cardiac diagnostics, increasing awareness regarding cardiovascular health, and expansion of specialty cardiac treatment centers."

Middle East & Africa 2.9% share: "Gradual growth driven by healthcare modernization initiatives, rising investments in cardiovascular care infrastructure, and growing adoption of advanced medical imaging systems."

Speak to our analyst and get customization in the report as per your requirements:https://www.datamintelligence.com/customize/structural-heart-imaging-market?sai-v

Key Segments

➥ By Imaging Modality

Echocardiogram: Represents the dominant segment, driven by extensive use in real-time cardiac structure assessment, valve function evaluation, and pre- and post-procedural monitoring for structural heart interventions.

Angiogram (CT and MRI): Represents a rapidly growing segment, supported by increasing adoption of advanced cardiac imaging technologies for detailed anatomical visualization, surgical planning, and minimally invasive procedure guidance.

➥ By Procedure Type

Transcatheter Aortic Valve Replacement (TAVR): Represents the dominant segment, driven by rising prevalence of aortic stenosis and increasing preference for minimally invasive valve replacement procedures among elderly patients.

Surgical Aortic Valve Replacement (SAVR): Represents a significant segment, supported by continued utilization in complex valve replacement cases requiring open-heart surgical intervention.

Transcatheter Mitral Valve Repair (TMVR): Represents a rapidly growing segment, fueled by increasing advancements in catheter-based mitral valve therapies and rising adoption of minimally invasive cardiac procedures.

Left Atrial Appendage Closure (LAAC): Represents a growing segment, driven by increasing focus on stroke prevention in patients with atrial fibrillation who are unsuitable for long-term anticoagulation therapy.

Annuloplasty: Represents a moderate segment, supported by growing use in heart valve repair procedures to restore valve function and structural integrity.

Valvuloplasty: Represents a significant segment, fueled by increasing utilization in treating narrowed heart valves through balloon-based minimally invasive procedures.

Others: Represents an emerging segment, driven by ongoing advancements in structural heart repair technologies and innovative catheter-based intervention techniques.

➥ By Application

Diagnosis: Represents the dominant segment, driven by increasing demand for early detection of structural heart disorders through advanced imaging and non-invasive diagnostic technologies.

Surgery: Represents a rapidly growing segment, supported by rising volume of minimally invasive cardiac procedures and growing integration of imaging-guided surgical planning systems.

➥ By End User

Hospitals: Represents the dominant segment, driven by availability of advanced cardiac imaging infrastructure, multidisciplinary surgical teams, and high procedural volumes for structural heart interventions.

Specialty Clinics: Represents a significant segment, supported by increasing establishment of specialized cardiovascular treatment facilities and outpatient cardiac care services.

Cardiac Centers: Represents a rapidly growing segment, fueled by rising focus on dedicated heart care institutions equipped with advanced imaging and interventional cardiology technologies.

Diagnostic Centers: Represents a growing segment, driven by increasing demand for non-invasive cardiac imaging and specialized diagnostic evaluations.

Ambulatory Surgical Centers: Represents a moderate segment, supported by growing adoption of minimally invasive cardiovascular procedures in outpatient surgical settings.

Others: Represents an emerging segment, fueled by expanding utilization in academic institutes, research organizations, and integrated healthcare facilities.

Unlock 360° Market Intelligence with DataM Subscription Services: https://www.datamintelligence.com/reports-subscription

Power your decisions with real-time competitor tracking, strategic forecasts, and global investment insights all in one place.

✅ Competitive Landscape
✅ Sustainability Impact Analysis
✅ KOL / Stakeholder Insights
✅ Unmet Needs & Positioning, Pricing & Market Access Snapshots
✅ Market Volatility & Emerging Risks Analysis
✅ Quarterly Industry Report Updated
✅ Live Market & Pricing Trends
✅ Import-Export Data Monitoring

Have a look at our Subscription Dashboard: https://www.youtube.com/watch?v=x5oEiqEqTWg

Contact:
Fabian
DataM Intelligence 4market Research LLP
6th Floor, M2 Tech Hub, DataM Intelligence 4market Research LLP, Lalitha Nagar, Habsiguda, Secunderabad, Hyderabad, Telangana 500039
USA: +1 877-441-4866
UK: +44 161-870-5507
Email: fabian@datamintelligence.com

About Us -

DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.

Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.